APA (7th ed.) Citation

J, E., S, G., AX, Q., PS, J., AR, H., & DJ, P. (2020). Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting. Genes, 11(5), . https://doi.org/10.3390/genes11050501

Chicago Style (17th ed.) Citation

J, Euesden, Gowrisankar S, Qu AX, Jean PS, Hughes AR, and Pulford DJ. "Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting." Genes 11, no. 5 (2020). https://doi.org/10.3390/genes11050501.

MLA (9th ed.) Citation

J, Euesden, et al. "Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting." Genes, vol. 11, no. 5, 2020, https://doi.org/10.3390/genes11050501.